Article Information
History
- July 3, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Nightingale Health UK Biobank Initiative,
- Heli Julkunen1,
- Anna Cichońska1,
- P. Eline Slagboom2,3 and
- Peter Würtz1,*
- 1Nightingale Health Ltd, Helsinki, Finland
- 2Molecular Epidemiology, Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands
- 3Max Planck Institute for Biology of Ageing, Cologne, Germany
- ↵*Address for Correspondence
Peter Würtz, Nightingale Health Ltd, Mannerheimintie 164a, 00300 Helsinki, Finland; peter.wurtz{at}nightingalehealth.com
Posted July 03, 2020.
Blood biomarker score identifies individuals at high risk for severe COVID-19 a decade prior to diagnosis: metabolic profiling of 105,000 adults in the UK Biobank
